Cutera (CUTR) has a profit margin of -84.86%, below the Healthcare sector average of 14.34%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2024
Trailing 12 months ending Sep 2024
The latest profit margin for CUTR is -84.86% as of September 2024. That compares with -47.26% in the prior-year period — down 79.5% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Cutera's historical trend and sector peers before judging valuation or financial health.
Over the past year, CUTR's profit margin moved from -47.26% to -84.86% — a 79.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cutera's valuation or profitability profile.
Against Healthcare companies, CUTR currently prints -84.86% for profit margin, while the sector average sits near 14.34%. That is roughly 691.6% below the sector mean. Large gaps often invite a closer look at Cutera's growth, margins, and balance sheet.
Profit Margin shows how effectively Cutera converts resources into returns. At -84.86%, CUTR may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -47.26% in the prior-year period — down 79.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting CUTR's profit margin (-84.86%), review year-over-year change from -47.26%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.